IOSP.NASDAQInnospec INC

Form 4: Innospec Director Leslie J. Parrette Acquires Shares Through Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Director Leslie J. Parrette acquired 1,209 shares of Innospec Inc. common stock through restricted stock units on February 24, 2025.

Summary

  • On February 24, 2025, Leslie J. Parrette, a director of Innospec Inc., acquired 1,209 shares of common stock.
  • The acquisition was through Restricted Stock Units (RSUs) granted in connection with Parrette's service as a non-employee director.
  • These RSUs will vest in full on February 24, 2028.
  • Following the transaction, Parrette directly owns 5,943 shares of Innospec Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction by a company director. The acquisition of shares can be seen as a positive sign, but it's not a major event.

Positives

  • The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates a director's acquisition of shares, which is a common occurrence.

Stakeholder Impact

  • The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates

DateDescription
02/24/2025Date of transaction: Leslie J. Parrette acquired 1,209 shares of Innospec Inc. common stock through RSUs.
02/24/2028Vesting date for the Restricted Stock Units (RSUs).
02/27/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.